Severe Disseminated Tuberculosis in Late Pregnancy During Infliximab Therapy for Crohn’s Disease Complicated by a Paradoxical Inflammatory Reaction
We report the case of a 30-year-old woman with Crohn’s disease treated with infliximab and previously treated for latent tuberculosis (TB) who presented at 36 weeks of gestation with cough, dyspnea, and preterm prelabor rupture of membranes. Her condition rapidly deteriorated with acute pulmonary edema, new-onset atrial fibrillation, and respiratory failure, requiring urgent cesarean delivery. Bronchoalveolar lavage confirmed infection with drug-susceptible Mycobacterium tuberculosis complex, and standard four-drug anti-TB treatment was initiated. Following infliximab discontinuation, she developed hypoxemic respiratory failure. Imaging showed miliary TB with pleural, hepatic, and splenic involvement. After exclusion and treatment of concomitant bacterial infection, a paradoxical TB-associated immune reconstitution inflammatory syndrome was suspected. She improved with high-dose methylprednisolone and high-flow nasal oxygen. Her course was complicated by tuberculous pleural effusion, pneumothorax, and catheter-related Candida albicans candidemia, but she ultimately recovered with continued TB therapy. This case highlights the risk of severe disseminated TB in pregnant patients receiving tumor necrosis factor (TNF)-alpha inhibitors, despite previous treatment for latent TB, and the challenge of recognizing paradoxical inflammatory deterioration after anti-TNF withdrawal.
Authors
- Abraham Van Poppel
- Éric Florence (ORCID: https://orcid.org/0000-0002-7004-9120)
- Symen Ligthart
- Maarten Claes
Institutions
- Antwerp University Hospital (BE)
Publication Details
- Journal
- Cureus
- Published
- 2026-11-16
- DOI
- https://doi.org/10.7759/cureus.119737
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00